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The induction of thymocyte apoptosis through the Nur77-mediated intrinsic pathway can be of physiological importance in the clonal deletion
of autoreactive thymocytes during negative selection in the thymus and/or in thymocytes undergoing oncogenic transformation. Ionomycin
treatment induces endogenous Nur77 expression as well as apoptosis and cytochrome c release in thymocytes. Here it is shown for the first time
that in normal thymocytes undergoing apoptosis, ionomycin induces translocation of endogenous Nur77 not only to the nucleus, but also to
mitochondria. Immunosuppressant FK506 inhibits Nur77 NBRE and NurRE binding activity but has no effect on thymocytes apoptosis, the
subcellular localization of Nur77, or cytochrome c release. This indicates that thymocytes can undergo apoptosis through the intrinsic Nur77-
mediated mitochondrial pathway and that the transactivation activity of Nur77 monomers or dimers is not necessary for thymocyte apoptosis.
© 2007 Elsevier B.V. All rights reserved.Keywords: Thymocytes; Apoptosis; Nur77; Mitochondrial translocation; DNA-binding1. Introduction
Nur77 (TR3, NGFI-B), a member of the steroid nuclear
orphan receptor family, has been shown to play a role in
apoptosis in the thymus [reviewed in [1,2], apoptosis of
neuronal cells [3], and the regulation of hormone expression
in the adrenal cortex [4]. As Nur77 may act as a transcription
factor, three Nur77 binding elements have been identified:
NBRE binding monomers of Nur77 protein [5], NurRE binding
homodimers of Nur77 [6], and DR-5 binding heterodimers with
proteins of the RXR family [7,8]. Nur77 can also be present on
mitochondrial membrane and was reported to interact with Bcl-
2 protein [9].
Constitutive Nur77 expression in mice results in massive
thymocyte death and leads to decreased numbers of thymocytes
and mature lymphocytes, while the expression of a dominant
negative mutant of Nur77 (as well as antisense nur77) inhibits
TCR (T-cell receptor)-induced apoptosis of developing T cells,⁎ Corresponding author. Tel.: +48 71 3371172; fax: +48 71 3371382.
E-mail address: strzadal@iitd.pan.wroc.pl (L. Strzadala).
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doi:10.1016/j.bbamcr.2007.05.011suggesting a role of Nur77 in the negative selection of
thymocytes [10,11]. There are two distinct mechanisms of
thymocyte apoptosis, i.e. through extrinsic and/or intrinsic
pathways. The intrinsic pathway involves the Bcl-2 and IAP
family members, whereas the extrinsic pathway is initiated by a
death receptor (Fas, TRAIL) [12,13]. Recently it was shown
that adenosine can induce apoptosis of thymocytes and that this
process is dependent on Bim, Bcl-2, and Nur77 [14].
In T cells, the expression of Nur77 is induced by an elevated
intracellular calcium level as a result of TCR activation
(mimicked by ionomycin treatment) [10,11]. It is believed
that Nur77 may contribute to the extrinsic pathway by acting as
a transcription factor and promoting the expression of pro-
apoptotic genes such as FasL, TRAIL, and NDG1 [15–17], but
the manner in which Nur77 regulates FasL or TRAIL
expression is unclear, as the element responsive to Nur77 has
still not been identified in the promoters of these genes. On the
other hand it has been reported that in several cancer cell lines
[9,18–20] and peripheral blood lymphocytes [9] the induction
of apoptosis through the intrinsic pathway may depend on
mitochondrial targeting of Nur77 or GR-receptors in response
to an apoptotic signal [21,22]. Interaction of Nur77 with Bcl-2
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changes within Bcl-2 and conversion of this anti-apoptotic
protein to a proapoptotic one. This event enables the release of
cytochrome c and activation of the caspases cascade [9]. This
mode of Nur77 action is independent of its transactivation
function. Using a transgenic mouse model it was shown that
in apoptotic Nur77 transgenic thymocytes, cytoplasmic
cytochrome c could not be detected, suggesting a negligible
role of the intrinsic apoptosis pathway in thymic development
[15].
Recently we showed that the induction of Nur77 by
ionomycin and its NBRE binding is not sufficient to initiate
the apoptotic process in a thymic lymphoma cell line [23].
Moreover, prevention of ionomycin-induced endogenous
Nur77 DNA binding with the immunosuppressant FK506
results in extensive apoptosis of thymic lymphomas, suggesting
that Nur77 acts rather through intrinsic pathways. In this paper
we investigate the release of cytochrome c in apoptotic
thymocytes, endogenous Nur77 expression in normal thymo-
cytes, its cellular localization, and its ability to induce apoptosis.
Additionally we studied the binding of endogenous Nur77 to its
response elements (NBRE or NurRE), showing that ionomycin-
induced apoptosis of thymocytes is independent of NBRE or
NurRE Nur77 binding.
2. Materials and methods
2.1. Chemicals and reagents
Iscove's modified Dulbecco's medium was from Gibco; FCS was from
Boehringer Mannheim; FK506 was a generous gift from Dr. M.Wasik, University
of Pennsylvania (USA) or was purchased from Calbiochem; ethanol, methanol and
glycerol were from POCh; NBRE oligonucleotide was from Bionovo, NurRE
oligonucleotide from IntegratedDNATechnologies; CREBoligonucleotide andT4
Polynucleotide Kinase were from Promega; poly(dI–dC)·poly(dI–dC) was from
Amersham Biosciences; γ-32P-ATP was from New England Nuclear; ECL was
from Pierce; Nonidet P-40, β-mercaptoethanol, antibiotics, ionomycin, propidium
iodide, Protease Inhibitor Coctail, Triton X-100, paraformaldehyde, horse serum,
Tris, PMSF and remaining chemicals were obtained from Sigma Aldrich.
Antibodies: anti-Nur77, anti-CREB, anti-Hsp60, anti-histone H1 and anti-actin
antibodies were from Santa Cruz Biotechnology; anti-goat and anti-rabbit
horseradish peroxidase-labeled antibodies were from DAKO; anti-rabbit IgG
conjugated with Alexa Fluor 488 was from Molecular Probes; anti-goat IgG and
anti-mouse IgG conjugated with Cy3 were from Jackson Immuno Research; anti-
cytochrome c antibody was from BD Biosciences.
2.2. Treatment of cells
Thymocytes obtained from C57BL/6 mice (2–3 months old) were cultured
at 37 °C in 5% CO2 in 24-well tissue culture plates, 10
6/ml, in Iscove's Modified
Dulbecco's medium supplemented with 20 μM β-mercaptoethanol, 100 U/ml
penicillin, 100 μg/ml streptomycin, and 10% FCS. The cells were treated with
1 μg/ml of ionomycin or 40 nM of FK506.
2.3. Detection of apoptosis
The detection of apoptosis was based on DNA content evaluation with the use
of propidium iodide and flow cytometry [24]. Briefly, after 22 h of treatment, the
cells were washed twice with phosphate-buffered saline (PBS) containing 2.5%
FCS, fixed with 70% ethanol for 30min at 4 °C, and then, after washing with PBS,
the cells were stained with propidium iodide (50 μg/ml in PBS without Ca2+,
Mg2+) overnight at 4 °C. The cell suspensions were analyzed with a FACS Caliburflow cytometer (Becton Dickinson). DNA content was evaluated on the basis of
FL-2 histograms using WinMDI 2.8 software. Apoptosis was quantified as the
percentage of cells with hypodiploidal DNA content.
2.4. Nuclear extracts preparation
Nuclear extracts were prepared as described previously [25] with minor
modifications. Cells were washed in cold PBS and suspended in three volumes
of buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM
EGTA, 1 mM DTT, 1 mM PMSF, 0.1 mM sodium orthovanadate, and 0.2%
Nonidet P-40, protease inhibitors, incubated on ice for 15 min, and centrifuged
at 10,000 rpm at 4 °C for 10 min. The pellets were washed once with buffer A
and resuspended in three volumes of buffer B (20 mM HEPES, pH 7.9, 10 nM
KCl, 1 mM EDTA, 1 mM EGTA, 420 mM NaCl, 20% glycerol, 1 mM DTT,
1 mM PMSF and protease inhibitors) and nuclear proteins were extracted by
rocking for 30 min at 4 °C. After centrifugation (10,000 rpm, 10 min) the
supernatants were stored at −70 °C in small aliquots. Protein concentrations
were determined using BCA.
2.5. Electromobility shift and supershift assays
Double-stranded consensus oligonucleotides, NBRE: 5′-TCGAGTTT-
TAAAAGGTCATGCTCAATTTG-3′ [18], NurRE: 5′-GATCCTAGTGATATT-
TACCTCCAAATGCCAGGA-3′ [6] and CRE: 5′-AGAGATTGCCTGAC-
GTCAGAGAGCTAG-3′ [26] were 5′ end-labeled with γ-32P-ATP by T4
Polynucleotide Kinase. Nuclear extracts (5 μg) were incubated with binding
buffer (1 mMMgCl2, 0.5 mM EDTA, 0.5 mMDTT, 50 mMNaCl, 10 mM Tris–
HCl, pH 7.5, 4% glycerol) and 0.25 mg/ml (for NBRE and CRE) or 0.03 mg/ml
(for NurRE) of poly(dI–dC)·poly(dI–dC) for 15 min at room temperature. After
addition of labeled oligonucleotides, the incubation proceeded for 30 min.
DNA–protein complexes were resolved on 6% native polyacrylamide gel in
TBE buffer (45 mM Tris–borate, pH 8.3, 1 mM EDTA). The gels were
incubated overnight at −20 °C with a storage phosphor screen (Molecular
Dynamics) and scanned with a Typhoon 8600 multi-imager (Molecular
Dynamics/Amersham Pharmacia Biotech). The specificity of the complex
formation was confirmed by performing the binding reactions in the presence of
a 50-fold excess of unlabelled oligonucleotides or by 1 h preincubation of
nuclear extracts with 2 ìg of anti-Nur77 (clone M210) antibody recognizing
DBD domain [27–29].
2.6. Confocal microscopy
Immunofluorescence analysis was performed as described previously [30],
with minor modifications. After treatment, the cells were fixed in 4%
paraformaldehyde in phosphate-buffered saline (PBS) for 30 min at 37 °C and
washed three times with PBS. The cells were then permeabilized with 0.15%
Triton X-100 in PBS containing 10% horse serum for 1 h at room
temperature. The washed cells were incubated overnight with polyclonal
antibodies: anti-Nur77 or anti-CREB (at a 1:200 dilution) and anti-Hsp60
(1:20), followed by one-h staining with secondary antibodies: anti-rabbit IgG
conjugated with Alexa Fluor 488 (1:200) and anti-goat IgG conjugated with
Cy3 (1:400). For cytochrome c staining, cells were incubated with
monoclonal anti-cytochrome c IgG followed by anti-mouse IgG conjugated
with Cy3 (1:400). Antibodies were diluted in permeabilization buffer. After
triple washing with PBS, the cell suspensions were placed onto microscope
slides and directly subjected to visualization under a confocal microscope
(Bio-Rad MRC-1024ES) with the use of a 10% laser. For each experiment,
controls were performed, including the examination of samples without
primary antibodies staining.
2.7. Subcellular fractionation
To obtain mitochondrial, nuclear, and cytosolic fractions we used the
Mitochondria Isolation Kit. Briefly, cells were washed twice with cold PBS and
lysed. After centrifugation at 800×g for 10 min, the nuclear pellet was washed
with lysis buffer, centrifuged at 1000×g for 10 min, suspended in SDS sample
buffer, and sonicated. The postnuclear supernatant was centrifuged at 10,000×g
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and the clear supernatant was used as a cytosolic fraction.
2.8. Western blotting
Cell fractions were boiled and subjected to SDS-PAGE on 12% gel. The
resolved proteins were transferred to PVDF membrane (Milipore). After
transfer, the membrane was blocked with 1% casein in TBS and then incubated
with 1 μg/ml rabbit anti-Nur77 antibody (M-210) followed by secondary
horseradish peroxidase-labeled antibodies (DAKO). The bound antibodies were
visualized using the ECL blotting detection system.
2.9. Measurement of cytochrome c level
Concentration of cytochrome c in the cytosol of thymocytes was measured
by an ELISA kit (RD Systems) according to the manufacturer's procedure.
3. Results
3.1. Ionomycin treatment leads to the induction of Nur77
expression, cytochrome c release, and apoptosis of thymocytes
TCR activation with subsequent intracellular calcium level
increase leads to programmed cell death of autoreactive
thymocytes. Calcium ionophores, such as ionomycin, can
mimic this process in vitro. In our experiments, 75–90% of
cells underwent apoptosis, quantified as the percentage of cells
with hypodiploidal DNA content, after 22 h treatment with
1 μg/ml of ionomycin. During this time, spontaneous apoptosis
occurred in 25–40% of untreated thymocytes incubated at
37 °C (Fig. 1A) and in 0–2% of cells incubated at 4 °C (data
not shown). After 2 h incubation with ionomycin we observed
about 7% cells undergoing apoptosis (Fig. 1A), the same
percentage of apoptotic thymocytes is observed in untreated
probes (not shown). 6 h treatment with ionomycin resulted in
30% apoptosis versus about 15% without treatment. An
increased level of intracellular calcium induces the expression
of endogenous Nur77, a nuclear receptor thought to be
indispensable for TCR-dependent apoptosis. In accordance
with other authors' results, we observed high expressions of
Nur77 in whole cell extracts after 2 and 6 h of incubation (Fig.
1B). This demonstrates that the consequences of in vitro
ionomycin treatment in our model are consistent with a pivotal
event in calcium-mediated apoptosis in thymocytes. In
untreated cells, incubated at 37 °C, endogenous Nur77 protein
level was insignificant and time-independent (Fig. 1B, lanes 1
and 3).
Using confocal microscopy we investigated whether cyto-
chrome c is released from the mitochondria to the cytosol in
thymocytes undergoing ionomycin-induced apoptosis. In
untreated cells, cytochrome c displayed mainly a punctate,
peripheral pattern of localization, corresponding to the
distribution of mitochondria in thymocytes. After 6 h of
ionomycin treatment, cytochrome c could be seen as a diffused
mist around the nuclei (Fig. 1C). Release of cytochrome c to the
cytosol was confirmed by ELISA. We managed to detect an
approximately fourfold increase in the concentration of
cytochrome c in the cytosol of the thymocytes treated for 6 h
with ionomycin (Fig. 4B).3.2. Ionomycin-induced Nur77 NBRE and NurRE binding
activity is inhibited by FK506
TCR-induced Nur77 is capable of NBRE and NurRE binding.
Likewise, we detected NBRE as well as NurRE binding in the
nuclear extracts of ionomycin-treated thymocytes (Fig. 2A, B,
lanes 2 and 4). The specificity of the complex formation was
confirmed by preincubation with cold oligonucleotides (Fig. 2
lane 6, 8) and assay using antibodies raised against an epitope
within DNA-binding domain of Nur77 protein (Fig. 2 lane 9).
Binding of the transcription factor CREB was used as a control of
protein content in the nuclear extracts (Fig. 2C).
Recently we found that FK506 was able to inhibit endogenous
Nur77DNA-binding activity in thymic lymphomas [21]. Nowwe
studied the effect of FK506 [31,32], on endogenous Nur77
binding activity in normal thymocytes. We found that in
thymocytes, as in thymic lymphomas, the immunosuppressant
FK506 prevented the DNA binding of monomers of endogenous
Nur77 to NBRE (Fig. 2A, lanes 3 and 5) and homodimers of
Nur77 to NurRE (Fig. 2B, lanes 3 and 5) 2 h as well as 6 h after
ionomycin treatment. The presence of FK506 has no influence on
the DNA-binding activity of CREB (Fig. 2C).
3.3. Inhibiting NBRE and NurRE binding activity by FK506
has no effect on the mitochondrial localization of Nur77
Nur77 mitochondrial targeting as a prerequisite for the
apoptotic process has been observed in numerous cancer cell
lines [9,18–20] and peripheral T lymphocytes [9], but not in
thymocytes so far. To ascertain this possibility, we performed
confocal immunofluorescence studies on the subcellular
localization of endogenous Nur77 in thymocytes treated with
ionomycin alone and ionomycin with FK506. We observed co-
localization (yellow) of Nur77 protein (green) and Hsp60 (red),
used as a marker of mitochondria, upon 6 h of ionomycin
treatment in about 30–40% of cells. Addition of FK506 did not
abrogate Nur77 mitochondrial localization in contrast to DNA
binding. No mitochondrial localization of CREB could be
observed (Fig. 3A) under the same conditions.
For a further additional check of the intracellular localization
of Nur77, we fractionated thymocytes into mitochondrial,
nuclear, and cytosolic fractions. The purity of each fraction was
analyzed by Western blotting with appropriate organelle
markers (Fig. 3C). Using Western blotting we analyzed the
expression of Nur77 in the fractionated thymocytes untreated
and treated with ionomycin for 0.5, 1, 2 and 6 h. Nur77 protein
is rapidly induced after 1-h incubation and present mainly in
cytosol. Prolonged time of incubation results in redistribution of
Nur77 to the mitochondria and nucleus. While after 6 h of
treatment, Nur77 was mainly localized on the thymocyte
mitochondria. FK506 did not significantly alter the localization
of Nur77 (Fig. 3B).
There is no significant difference between the amount of
Nur77 protein in the nucleus of thymocytes treated with FK506
and ionomycin compared with treatment with ionomycin alone.
However, the differences in DNA binding by Nur77 in the
presence of FK506 are clear (Fig. 2, lanes 3 and 5).
Fig. 1. Ionomycin induces thymocytes apoptosis, Nur77 expression, and release of cytochrome c. (A) Flow cytometric analysis of thymocytes apoptosis. Cells were
treated as described for indicated time and stained with propidium iodide to visualize DNA fragmentation. Apoptosis was quantified as the percentage of cells with
hypodiploidal DNA content with the use of the WinMDI program. Representative histograms are shown. (B) Western blot of Nur77 protein present in whole cell
lysates from thymocytes cultured for 2 and 6 h in the presence of ionomycin or in medium only. Results representative of two experiments are shown (C) Cytochrome c
release into the cytosol in response to ionomycin. Thymocytes were treated for 6 h, stained with anti-cytochrome c antibody and Cy3-labeled secondary antibody (red),
and then examined by confocal microscopy. Representative pictures are shown.
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apoptosis and cytochrome c release
The exact mechanism of Nur77 action in the negative
selection of thymocytes is controversial (DNA-binding vs.
mitochondrial translocation or both). The release of cytochromec to the cytosol initiates the activation of caspase-9, and
subsequently caspase-3. Inhibiting DNA-binding activity by
FK506 had no influence on ionomycin-induced apoptosis (Fig.
4A) and cytochrome c release (Fig. 4B). We detected by ELISA
an approximately fourfold increase in the concentration of
cytochrome c in the cytosol fractions of thymocytes treated for
Fig. 2. Nur77 DNA-binding activity in apoptotic thymocytes. Nuclear extracts were incubated with P32-labeled double-stranded oligonucleotide containing NBRE (A)
or NurRE (B) and separated electrophoretically in native conditions. U—untreated cells, I—ionomycin, IFK—ionomycin+ FK506. As a control, a probe containing
the CRE sequence was used (C). For NBRE and NurRE, the unbound probe was run off the gel for improved DNA–protein complex visibility and is not shown. The
specificity of the complex formation was confirmed by preincubation of the nuclear extracts with a 50-fold excess of unlabelled consensus oligonucleotides (lanes 6, 8)
or with anti-Nur77 antibody raised against an epitope located within DNA-binding domain (lane 9). Representative results are shown. Lines indicate image
manipulation in order to crop irrelevant data.
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apoptosis. The immunosuppressant alone influenced neither the
viability of the cells nor cytochrome c content in the cytosol.
To explain how apoptosis is induced in our model, we
examined the effect of FK506. We demonstrated that FK506
inhibits Nur77 DNA binding, but not mitochondrial transloca-
tion or ionomycin-induced cytochrome c release (Fig. 4A) and
apoptosis of thymocytes (Fig. 4B). We show here for the first
time that in thymocytes, FK506 blocks DNA binding by Nur77,
but prevents neither Nur77 mitochondrial targeting, nor
cytochrome c release, nor cell death. In other words, the ability
of both monomers and homodimers of Nur77 to bind DNA is
dispensable for its proapoptotic function in immature T cells.
Hence, mitochondrial translocation is probable mechanism of
Nur77 action in the thymus.
4. Discussion
Nur77 was shown to take part in the negative selection of
thymocytes. Genetic manipulation with the expression of Nur77
(constitutive expression as well as the introduction of a
dominant negative mutant) resulted in an abnormal image of
the thymus. Data collected to date suggest that Nur77 regulatesapoptosis of T cells via its transactivation activity. Using
transgenic mice with constitutive expression of Nur77, Rajpal et
al. [15] reported that Nur77-mediated apoptosis in thymocytes
does not involve Nur77 mitochondrial targeting and cyto-
chrome c release. However, it was shown in these mice [33] that
constitutive expression of Nur77 leads to a dramatic decrease
(20-fold) in their thymocyte cellularities, leaving alive mostly
DN (double negative) thymocytes, but lacking DP (double
positive) thymocytes. It should be noted that in the normal
thymus, DP thymocytes comprise about 85% of the total
thymocytes and that this subpopulation of thymocytes is under
negative selective pressure [34].
Rajpal et al. suggested that in thymocytes, Nur77 induces
apoptosis by a Bcl2/mitochondrial-independent mechanism
[15]. Several authors also observed strong correlation between
Nur77 DNA-binding activity and apoptosis as well as TRAIL
induction in cancer cells [16,17]. Nur77 is believed to exert its
effect in cells by activating the transcription of proapoptotic
genes and/or by silencing the transcription of anti-apoptotic
ones [35,36], but there is no direct evidence that Nur77 acts this
way. Rajpal et al. discovered novel proapoptotic genes down-
stream from Nur77 involved in a novel apoptotic pathway
activating caspase-8 and that Nur77 could play a role as a
Fig. 3. Endogenous Nur77 translocation to mitochondria in response to ionomycin. (A) Cells were stimulated with either ionomycin alone or ionomycin with FK506
for 6 h. Fixed and permeabilized cells were stained for endogenous Nur77 or CREB with the use of specific antibodies followed by Alexa Fluor-labeled secondary
antibody (green), and for mitochondria-specific protein Hsp60 with Cy3-labeled secondary antibody (red). The cells were then examined by confocal microscopy.
Nur77 colocalized with Hsp60 (yellow), contrary to CREB used as a control. Representative results are shown as overlays. (B) Western blot analysis of the distribution
of Nur77 in the cytosolic, nuclear, and mitochondrial fractions after treatment of thymocytes with ionomycin or ionomycin with FK506 for indicated time. One result
of each duplicate experiment is shown. (C) Confirmation of the purity of three fractions by Western blotting with the use of antibodies specific for actin, histone H1,
and Hsp60, which are specific markers of the cytosolic, nuclear, and mitochondrial fractions, respectively.
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TRAIL [15]. However, it remains unclear whether these
potential downstream genes are direct transcriptional targets
of Nur77, as in the FasL promoter there is no consensus
sequences for Nur77 binding, and in mice carrying the gld/gld
FasL mutation or CD30 mutation [37,38], thymocyte apoptosis
was not altered.Here we have shown that in a normal thymocyte population,
as in thymic lymphomas developed from HY-transgenic mice
(Rapak et al., submitted), endogenous Nur77 translocates to
mitochondria as well as to the nucleus upon a calcium signal.
We noticed that in normal thymocytes and thymic lymphomas,
Nur77 presence in the nucleus is relatively short compared with
its presence on mitochondria, where Nur77 has a tendency to
Fig. 4. FK506 influences neither thymocyte apoptosis nor cytochrome c release.
(A) Apoptosis of thymocytes was measured as the percentage of cells with
hypodiploidal DNA content after 22 h of treatment. (B) Concentration of
cytochrome c in the cytosol of thymocytes after 6 h of incubation was measured
by an ELISA kit (RD Systems) according to the manufacturer's procedure. The
bars represent the average±mean of four experiments.
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targeting was accompanied by cytochrome c release in cells
undergoing apoptosis. These results strongly suggest that in T
cells, as it was shown in prostate cancer and other cancer cells
[9,18–20,39], Nur77 may induce apoptosis via an intrinsic
pathway involving cytochrome c release, induction of FasL
expression is rather secondary event, which takes part in
enhancing apoptotic response.
In previous studies on lymphomas we found that the
immunosuppressant and calcineurin [31] and JNK/p38 [32]
inhibitor FK506 has the ability to inhibit Nur77 binding to the
NBRE sequence [23]. We therefore applied this tool to examine
the importance of Nur77 binding to NBRE or NurRE consensus
sequences. We found that cytochrome c is released and normal
thymocytes underwent apoptosis upon calcium signaling even in
the absence of Nur77 binding to NBRE and NurRE sequences.
This shows that Nur77 binding activity to NBRE and NurRE is
not necessary for thymocyte apoptosis. On the other hand, FK506
treatment did not inhibit Nur77 mitochondrial translocation and
cytochrome c release. This suggests that endogenous Nur77 may
take a part in the regulation of thymocyte apoptosis also by the
intrinsic pathway and that its transactivation activity as a
monomer or homodimer is dispensable for apoptosis. Since
Nur77 binding to DNA is inhibited by FK506 the transcriptional
activity of Nur77 does not obviously take place. However, it isnot excluded that the transactivation activity of the heterodimer
of Nur77 with RXR [7,8] can also be engaged in the control of
the apoptosis of thymocytes.
Altogether, our results suggest that Nur77 can contribute to the
negative selection of thymocytes via translocation to the
mitochondria, acting as an adaptor protein facilitating the release
of cytochrome c to the cytosol. It is worth mentioning that it has
been shown that mutant Nur77 constructs lacking a DNA-binding
domain exerted stronger proapoptotic activity than the wild type
of the receptor [9,18,39] by facilitated mitochondria targeting.
The induction of thymocyte apoptosis through the Nur77-
mediated intrinsic pathway can be of physiological importance
in the clonal deletion of autoreactive thymocytes during negative
selection in the thymus and/or in thymocytes undergoing
oncogenic transformation. In agreement with these possibilities,
we found that thymic lymphomas from mice expressing
transgenic TCR autoreactive against male (HY) antigen were
resistant to TCR-mediated apoptosis [40], despite of nuclear
expression of Nur77 in these ionomycin-resistant lymphomas
[41]. This suggests that in thymocytes apoptosis can occur
through the Nur77-mediated mitochondrial intrinsic pathway and
that during oncogenic transformation of thymocytes this pathway
could be impaired, liberating tumor cells from host surveillance
mechanisms as well as from anticancer therapies.
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